Cladrim 10Mg Injection
10ml InjectionMRP ₹12362.00
₹9889.60
20% OFF
Made by
MSD PHARMACEUTICALS INDIAN PRIVATE LTD
Dosage
INJECTION
Expiry
Product Summary
| Uses | Hairy cell leukaemia |
| Therapy | Anti-neoplastic |
| Side effects | Fever, Nausea, Fatigue, Headache, Rash |
| Salt Content | Cladribine(10.0 Mg) |
Assurance
available
Regulated
Medical Description
Cladrim is an injection used to treat hairy cell leukaemia in adults under specialist care. Its active ingredient is cladribine.
Uses
- Hairy cell leukaemia
Contraindications
Side effects
- Fever
- Nausea
- Fatigue
- Headache
- Rash
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have an active infection, as Cladrim injection can suppress the immune system and may increase the risk of serious infection.
- You have low blood-cell counts, as Cladrim injection treatment can further reduce red cells, white cells, and platelets.
- You have kidney impairment, as caution is advised because renal toxicity has been reported, particularly with high-dose treatment.
- You develop severe weakness, difficulty moving your arms or legs, or other neurological symptoms, as serious neurological toxicity has been reported.
- You develop unusual bruising or bleeding, as this may indicate a low platelet count.
- You develop fever, particularly during the first month after treatment, because fever and serious infections are common during this period.
Directions for Use
Storage and disposal
Quick Tips
- Keep all blood-test appointments.
- Tell your doctor promptly about fever, infection, unusual bleeding, or bruising.
- Avoid live vaccines unless your specialist approves them.
Dosage
Missed a Dose
Overdose
How does this medicine work?
Interactions
Interactions with other medicines
Interactions with food items
Frequently Asked Questions (FAQs)
References:
- DailyMed. Cladribine injection, solution [Internet]. Bethesda (MD): National Library of Medicine (US); [updated 2024 Oct 10; cited 2026 Aug 11]
- U.S. Food and Drug Administration. Leustatin (cladribine) injection: Orphan drug designation and approval [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 1993 Feb 26 [cited 2026 Aug 11].
- European Medicines Agency. Litak (cladribine): EPAR and product information [Internet]. Amsterdam: European Medicines Agency; [cited 2026 Aug 11].
- Central Drugs Standard Control Organisation (CDSCO). Drugs@CDSCO [Internet]. New Delhi: Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India; [cited 2026 Aug 10].
Articles
View All
Chronic Condition Articles
View All
Did you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:CLADRIM
Vendor Details
Fulfillment Information: Cladrim 10 MG Injection (10) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
